346 related articles for article (PubMed ID: 17032249)
1. Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile.
Sathler-Avelar R; Vitelli-Avelar DM; Massara RL; Borges JD; Lana M; Teixeira-Carvalho A; Dias JC; Elói-Santos SM; Martins-Filho OA
Scand J Immunol; 2006 Nov; 64(5):554-63. PubMed ID: 17032249
[TBL] [Abstract][Full Text] [Related]
2. Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease.
Vitelli-Avelar DM; Sathler-Avelar R; Teixeira-Carvalho A; Pinto Dias JC; Gontijo ED; Faria AM; Elói-Santos SM; Martins-Filho OA
Scand J Immunol; 2008 Nov; 68(5):516-25. PubMed ID: 18803607
[TBL] [Abstract][Full Text] [Related]
3. Blood leukocytes from benznidazole-treated indeterminate chagas disease patients display an overall type-1-modulated cytokine profile upon short-term in vitro stimulation with Trypanosoma cruzi antigens.
Sathler-Avelar R; Vitelli-Avelar DM; Elói-Santos SM; Gontijo ED; Teixeira-Carvalho A; Martins-Filho OA
BMC Infect Dis; 2012 May; 12():123. PubMed ID: 22625224
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.
Abrahamsohn IA; Coffman RL
Exp Parasitol; 1996 Nov; 84(2):231-44. PubMed ID: 8932773
[TBL] [Abstract][Full Text] [Related]
5. [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].
Laucella SA; Rottenberg ME; de Titto EH
Rev Argent Microbiol; 1996; 28(2):99-109. PubMed ID: 8768488
[TBL] [Abstract][Full Text] [Related]
6. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection.
Abel LC; Rizzo LV; Ianni B; Albuquerque F; Bacal F; Carrara D; Bocchi EA; Teixeira HC; Mady C; Kalil J; Cunha-Neto E
J Autoimmun; 2001 Aug; 17(1):99-107. PubMed ID: 11488642
[TBL] [Abstract][Full Text] [Related]
7. Coculture of human peripheral blood mononuclear cells with Trypanosoma cruzi leads to proliferation of lymphocytes and cytokine production.
Van Voorhis WC
J Immunol; 1992 Jan; 148(1):239-48. PubMed ID: 1727869
[TBL] [Abstract][Full Text] [Related]
8. Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity?
Vitelli-Avelar DM; Sathler-Avelar R; Massara RL; Borges JD; Lage PS; Lana M; Teixeira-Carvalho A; Dias JC; Elói-Santos SM; Martins-Filho OA
Clin Exp Immunol; 2006 Jul; 145(1):81-92. PubMed ID: 16792677
[TBL] [Abstract][Full Text] [Related]
9. [Immune responses of non-infected neonates of mothers infected with Trypanosoma cruzi].
Truyens C; Hermann E; Alonso-Vega C; Rodriguez P; Vekemans J; Torrico F; Carlier Y
Rev Soc Bras Med Trop; 2005; 38 Suppl 2():96-100. PubMed ID: 16482825
[TBL] [Abstract][Full Text] [Related]
10. Suppressive action of melatonin on the TH-2 immune response in rats infected with Trypanosoma cruzi.
Santello FH; Frare EO; dos Santos CD; Caetano LC; Alonso Toldo MP; do Prado JC
J Pineal Res; 2008 Oct; 45(3):291-6. PubMed ID: 18373553
[TBL] [Abstract][Full Text] [Related]
11. The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection.
Guillermo LV; Silva EM; Ribeiro-Gomes FL; De Meis J; Pereira WF; Yagita H; DosReis GA; Lopes MF
J Leukoc Biol; 2007 Apr; 81(4):942-51. PubMed ID: 17261545
[TBL] [Abstract][Full Text] [Related]
12. Immune response in human visceral leishmaniasis: analysis of the correlation between innate immunity cytokine profile and disease outcome.
Peruhype-Magalhães V; Martins-Filho OA; Prata A; Silva Lde A; Rabello A; Teixeira-Carvalho A; Figueiredo RM; Guimarães-Carvalho SF; Ferrari TC; Correa-Oliveira R
Scand J Immunol; 2005 Nov; 62(5):487-95. PubMed ID: 16305646
[TBL] [Abstract][Full Text] [Related]
13. Cynomolgus macaques naturally infected with Trypanosoma cruzi-I exhibit an overall mixed pro-inflammatory/modulated cytokine signature characteristic of human Chagas disease.
Vitelli-Avelar DM; Sathler-Avelar R; Mattoso-Barbosa AM; Gouin N; Perdigão-de-Oliveira M; Valério-Dos-Reis L; Costa RP; Elói-Santos SM; Gomes MS; Amaral LR; Teixeira-Carvalho A; Martins-Filho OA; Dick EJ; Hubbard GB; VandeBerg JF; VandeBerg JL
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005233. PubMed ID: 28225764
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the cellular immune response in patients with the digestive and indeterminate forms of Chagas' disease.
Ribeiro BM; Crema E; Rodrigues V
Hum Immunol; 2008 Aug; 69(8):484-9. PubMed ID: 18582517
[TBL] [Abstract][Full Text] [Related]
16. Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults.
Silva ML; Martins MA; Espírito-Santo LR; Campi-Azevedo AC; Silveira-Lemos D; Ribeiro JG; Homma A; Kroon EG; Teixeira-Carvalho A; Elói-Santos SM; Martins-Filho OA
Vaccine; 2011 Jan; 29(3):583-92. PubMed ID: 20732465
[TBL] [Abstract][Full Text] [Related]
17. Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes.
Vitelli-Avelar DM; Sathler-Avelar R; Dias JC; Pascoal VP; Teixeira-Carvalho A; Lage PS; Elói-Santos SM; Corrêa-Oliveira R; Martins-Filho OA
Scand J Immunol; 2005 Sep; 62(3):297-308. PubMed ID: 16179017
[TBL] [Abstract][Full Text] [Related]
18. Reduction of parasite levels in blood improves pregnancy outcome during experimental Trypanosoma cruzi infection.
Solana ME; Alba Soto CD; Fernández MC; Poncini CV; Postan M; González Cappa SM
Parasitology; 2009 May; 136(6):627-39. PubMed ID: 19366478
[TBL] [Abstract][Full Text] [Related]
19. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.
Souza PE; Rocha MO; Menezes CA; Coelho JS; Chaves AC; Gollob KJ; Dutra WO
Infect Immun; 2007 Apr; 75(4):1886-94. PubMed ID: 17283096
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4 regulates the murine immune response to Trypanosoma cruzi infection.
Graefe SE; Jacobs T; Wächter U; Bröker BM; Fleischer B
Parasite Immunol; 2004 Jan; 26(1):19-28. PubMed ID: 15198642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
